LIXTE BIOTECHNOLOGY HOLDINGS
Lixte Biotechnology Holdings, Inc. is a clinical-stage public (LIXT) pharmaceutical company dedicated to discovering drugs for more effective treatments for cancer. Lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. The current drug portfolio includes inhibitors of protein phosphatases that are critical to cell division and DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.
LIXTE BIOTECHNOLOGY HOLDINGS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
East Setauket, New York, United States
Country:
United States
Website Url:
http://www.lixte.com
Total Employee:
1+
Status:
Active
Contact:
(631) 830-7092
Email Addresses:
[email protected]
Total Funding:
10.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.lixte.com Semrush global rank: 1.24 M Semrush visits lastest month: 24.48 K
- Host name: 74-208-236-39.elastic-ssl.ui-r.com
- IP address: 74.208.236.39
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
